Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
- PMID: 15172979
- DOI: 10.1158/0008-5472.CAN-04-0637
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
Abstract
In this study, we report for the first time reduced expression of the let-7 microRNA in human lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative resection could be classified into two major groups according to let-7 expression in unsupervised hierarchical analysis, showing significantly shorter survival after potentially curative resection in cases with reduced let-7 expression (P = 0.0003). Multivariate COX regression analysis showed this prognostic impact to be independent of disease stage (hazard ratio = 2.17; P = 0.009). In addition, overexpression of let-7 in A549 lung adenocarcinoma cell line inhibited lung cancer cell growth in vitro. This study represents the first report of reduced expression of let-7 and the potential clinical and biological effects of such a microRNA alteration.
Similar articles
-
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028859
-
Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.Oncol Rep. 2004 Oct;12(4):849-53. Oncol Rep. 2004. PMID: 15375511
-
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11. Lung Cancer. 2009. PMID: 18620780
-
Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.Cancer. 2007 Jul 1;110(1):215-23. doi: 10.1002/cncr.22743. Cancer. 2007. PMID: 17508409
-
Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.Cancer Res. 2010 Dec 15;70(24):10392-401. doi: 10.1158/0008-5472.CAN-10-2341. Cancer Res. 2010. PMID: 21159652
Cited by
-
Prospects of miRNA-based therapy for pancreatic cancer.Curr Drug Targets. 2013 Sep;14(10):1101-9. doi: 10.2174/13894501113149990181. Curr Drug Targets. 2013. PMID: 23834151 Free PMC article. Review.
-
Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.BMC Cancer. 2014 Dec 23;14:996. doi: 10.1186/1471-2407-14-996. BMC Cancer. 2014. PMID: 25539644 Free PMC article.
-
MicroRNA and cancer chemoprevention.Cancer Prev Res (Phila). 2013 May;6(5):401-9. doi: 10.1158/1940-6207.CAPR-13-0032. Epub 2013 Mar 26. Cancer Prev Res (Phila). 2013. PMID: 23531448 Free PMC article. Review.
-
Novel classes of non-coding RNAs and cancer.J Transl Med. 2012 May 21;10:103. doi: 10.1186/1479-5876-10-103. J Transl Med. 2012. PMID: 22613733 Free PMC article. Review.
-
Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma.Clin Transl Oncol. 2014 Mar;16(3):315-21. doi: 10.1007/s12094-013-1078-1. Epub 2013 Jul 18. Clin Transl Oncol. 2014. PMID: 23864279
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical